Founded by Michael Ryan, Koios E&C looks to break the traditional mold of healthcare consulting that has limited its value to the industry for decades.
Core to the philosophy of Koios Enterprises & Consulting is rather than force your challenge to fit the skillsets of the staff that we employ, Koios E&C constructs an individual team of experts that matches the therapeutic and business issues that you have. The professionals that we bring to the table have real-world experience and knowledge that is directly relevant to your issue.
Other consulting firms require countless hours of time interviewing and extracting the knowledge of your own staff to construct an answer that already existed within your organization. In contrast, we bring proven and experienced experts to the table who are capable of immediately providing new knowledge and insights that allow for a synergistic work effort with your staff that produces new and innovative solutions.
Our company philosophy is captured in our name; Koios the Greek Titan God of inquisitive thinking and intellect. Our mission is to bring new and creative thinking to the challenges you face today and tomorrow.
About Us
Our Leadership
Founder & CEO, Koios Enterprises & Consulting
Michael L. Ryan, PharmD
Dr. Ryan’s career extends for over 20 years in both academic provider healthcare at the Universities of Michigan and Pittsburgh, as well as over 20 years in the Pharma/Biotech industry at Amgen and Bristol-Myers Squibb (BMS). He has also served on the boards of PhRMA, BIO, National Pharmaceutical Council, the University of Southern California Schaeffer Center for Health Policy, and the Universities of Michigan and UCSF.
-
Graduate of the University of California at Los Angeles, and the University of California at San Francisco. He completed his residency program at the University of Michigan.
Dr. Ryan has been invited to present over 200 national platform presentations and has over 40 refereed journal and textbook publications.
The primary focus of Dr. Ryan’s research is U.S. and Worldwide health economics, biomedical informatics, and healthcare policy.
-
Reorganized BMS team into an industry leading VAP & HEOR organization
Responsible for access and pricing across Business Development and the product Lifecyle for the $44B BMS portfolio, and the management of >1,600 Market Access and Economics professionals in the US and 60+ countries.
Developed and submitted >1,000 HTA dossiers, with best-in-class 96% acceptance rates
Served on a number of BMS executive leadership teams including:
BMS Commercial Leadership Team
Digital Health Steering Committee
Commercial Innovation Strategy Team
Commercial Development Operating Committee
Business Development Steering Committee
Pipeline Steering Committee
Political Action Committee
Portfolio Strategy Governance Team
-
Responsible for the P&L and life cycle management of Amgen’s three products used to treat patients with kidney disease: Epogen®, Aranesp® and Sensipar®.
-
Responsible for all pricing, contracting, government price reporting, payer strategy, and value and access marketing across the $13B U.S. Amgen portfolio.
-
Established the clinical pharmacy program at UPMC, as well as the PharmD program at the School of Pharmacy
Held affiliated faculty appointments with both the University of Pittsburgh School of Medicine, Department of Clinical Pharmacology, and the School for Biomedical Informatics, and also served as the Co-Director for the UPMC Center for Biomedical Informatics.
Established seven for profit businesses, including the UPMC Health Plan, and Transplant and Oncology Centers outside of the US
Chair, Department of Clinical Pharmacy & Pharmacology
-
Directed all clinical pharmacy programs and P&T Committee actions at the University of Michigan Medical Center
Assisted in the conversion of the College of Pharmacy from a BS to a PharmD program
Established three for-profit programs including M-Care, Home-Med, and the U of M Med Inn